Testing effectiveness (Phase 2)Study completedNCT01562821
What this trial is testing
Safety and Efficacy of Activated Recombinant Human Factor VII in Cirrhotic Patients Undergoing Partial Hepatectomy
Who this might be right for
Acquired Bleeding DisorderCirrhosis
Novo Nordisk A/S 235